Physician profile

Ross Richard Melvin

Interventional Cardiology · Panama City, FL

NPI 1871856492

$13,866.50

in general payments reported to CMS, 2019-2025

40 companies · $2,251 in 2025

The $2,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,507.48
Travel and Lodging$425.46

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $2,738.80 2019-2024 Watchman Flx
Abbott Laboratories $1,489.37 2019-2025 Esprit, Diamondback Coronary, Diamondback Peripheral
Penumbra, INC. $1,374.81 2024-2025 Indigo System, Penumbra System, Ruby Coil
Shockwave Medical, INC $1,224.25 2020-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Philips North America LLC $725.80 2019-2022
Cardiovascular Systems INC. $706.28 2019-2022
Stryker Corporation $600.85 2025 Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt
Medtronic, INC. $467.60 2021-2023 Venaseal
Endologix LLC $444.78 2024-2025 Torus Stent Graft System, Endocross Device
Inari Medical, INC. $428.21 2023-2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Cardiva Medical, INC. $367.89 2020-2024 Cardiva Vascade Mvp Vvcs 6-12f
Angiodynamics, INC. $330.22 2023 Auryon Laser System 100-120 Vac, Alphavac
Novartis Pharmaceuticals Corporation $298.83 2021-2025
Pfizer INC. $271.80 2021-2025
Terumo Medical Corporation $228.85 2019
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $215.84 2019-2025 Lifevest
Amgen INC. $190.45 2021-2025 Repatha, Repatha
Abiomed $179.05 2019-2023 Impella
Tactile Systems Technology INC $167.85 2022
Boehringer Ingelheim Pharmaceuticals, INC. $144.04 2020-2022
E.R. Squibb & Sons, L.L.C. $139.50 2024-2025 Eliquis, Camzyos
Medtronic Vascular, INC. $126.48 2019
Merck Sharp & Dohme LLC $122.30 2021-2024 Verquvo
Venclose INC. $108.57 2020
Astrazeneca Pharmaceuticals LP $107.92 2019-2024 Farxiga
Janssen Pharmaceuticals, INC $107.33 2019-2022
Esperion Therapeutics, INC. $101.62 2020-2024 Nexletol
Cook Medical LLC $87.70 2019
Biosense Webster, INC. $86.98 2024 Carto 3
Bard Peripheral Vascular, INC. $50.53 2019-2022
Biotronik INC. $34.00 2021
Lexicon Pharmaceuticals, INC. $32.42 2024
Actelion Pharmaceuticals US, INC. $29.00 2022
Cagent Vascular INC $27.25 2025 Serrantor
Atricure, INC. $26.82 2023
Sanofi-Aventis U.S. LLC $23.60 2023
Itamar Medical INC $22.35 2023 Watchpatone
Inspire Medical Systems, INC. $17.49 2025 Inspire
Acacia Pharma INC $12.96 2021
Cvrx, INC. $6.11 2023 Barostim Neo System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ross Richard Melvin

$13,866.50

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $2,251 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/814967/ross-richard-melvin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.